Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1432-0584

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms ; volume:101 ; number:7 ; day:7 ; month:5 ; year:2022 ; pages:1567-1576 ; date:7.2022
Annals of hematology ; 101, Heft 7 (7.5.2022), 1567-1576, 7.2022

Creator: Vallejo, Miren
Muñiz, Paula
Kwon, Mi
Solán, Laura
Bailén, Rebeca
Carbonell, Diego
Chicano, María
Suárez-González, Julia
Catalán, Pilar
Bellón, José María
Triviño, Juan Carlos
Dorado, Nieves
Gallardo, David
Díez-Martín, José Luis
Ramírez, Natalia
Martínez-Laperche, Carolina
Buño, Ismael

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00277-022-04841-8

URN: urn:nbn:de:101:1-2022081020114845823669

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:30 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Vallejo, Miren
Muñiz, Paula
Kwon, Mi
Solán, Laura
Bailén, Rebeca
Carbonell, Diego
Chicano, María
Suárez-González, Julia
Catalán, Pilar
Bellón, José María
Triviño, Juan Carlos
Dorado, Nieves
Gallardo, David
Díez-Martín, José Luis
Ramírez, Natalia
Martínez-Laperche, Carolina
Buño, Ismael
SpringerLink (Online service)

Other Objects (12)

The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an evidence mapping

Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation

Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation

IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients

Epstein–Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non–Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL

Hochschulschrift

Immunrekonstitution CMV-spezifischer T-Zellen bei Patienten nach allogener Stammzelltransplantation : Quantifizierung mittels HLA-CMV-Tetramer-Komplexen

Hochschulschrift

Detektion CMV-spezifischer CD8+-T-Lymphozyten mittels sechs verschiedener CMV-HLA-Tetramer-Komplexe bei Patienten nach allogener Stammzelltransplantation

Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study

Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation

Association between migraine and HLA–DRB1 gene polymorphisms

High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation

CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor

The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an evidence mapping

Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation

Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation

IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients

Epstein–Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non–Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL

Hochschulschrift

Immunrekonstitution CMV-spezifischer T-Zellen bei Patienten nach allogener Stammzelltransplantation : Quantifizierung mittels HLA-CMV-Tetramer-Komplexen

Hochschulschrift

Detektion CMV-spezifischer CD8+-T-Lymphozyten mittels sechs verschiedener CMV-HLA-Tetramer-Komplexe bei Patienten nach allogener Stammzelltransplantation

Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study

Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation

Association between migraine and HLA–DRB1 gene polymorphisms

High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation

CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor

The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an evidence mapping

Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation

Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation

IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients

Epstein–Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non–Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL

Hochschulschrift

Immunrekonstitution CMV-spezifischer T-Zellen bei Patienten nach allogener Stammzelltransplantation : Quantifizierung mittels HLA-CMV-Tetramer-Komplexen

Hochschulschrift

Detektion CMV-spezifischer CD8+-T-Lymphozyten mittels sechs verschiedener CMV-HLA-Tetramer-Komplexe bei Patienten nach allogener Stammzelltransplantation

Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study

Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation

Association between migraine and HLA–DRB1 gene polymorphisms

High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation

CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an evidence mapping

Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation

Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation

IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients

Epstein–Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non–Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL

Immunrekonstitution CMV-spezifischer T-Zellen bei Patienten nach allogener Stammzelltransplantation : Quantifizierung mittels HLA-CMV-Tetramer-Komplexen

Detektion CMV-spezifischer CD8+-T-Lymphozyten mittels sechs verschiedener CMV-HLA-Tetramer-Komplexe bei Patienten nach allogener Stammzelltransplantation

Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study

Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation

Association between migraine and HLA–DRB1 gene polymorphisms

High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation

CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor

The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an evidence mapping

Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation

Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation

IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients

Epstein–Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non–Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL

Immunrekonstitution CMV-spezifischer T-Zellen bei Patienten nach allogener Stammzelltransplantation : Quantifizierung mittels HLA-CMV-Tetramer-Komplexen

Detektion CMV-spezifischer CD8+-T-Lymphozyten mittels sechs verschiedener CMV-HLA-Tetramer-Komplexe bei Patienten nach allogener Stammzelltransplantation

Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study

Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation

Association between migraine and HLA–DRB1 gene polymorphisms

High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation

CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor

The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: an evidence mapping

Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation

Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation

IL-23 plasma level is strongly associated with CMV status and reactivation of CMV in renal transplant recipients

Epstein–Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non–Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL

Immunrekonstitution CMV-spezifischer T-Zellen bei Patienten nach allogener Stammzelltransplantation : Quantifizierung mittels HLA-CMV-Tetramer-Komplexen

Detektion CMV-spezifischer CD8+-T-Lymphozyten mittels sechs verschiedener CMV-HLA-Tetramer-Komplexe bei Patienten nach allogener Stammzelltransplantation

Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study

Impact of antiviral treatment on long-term prognosis in non-immunocompromised patients with CMV reactivation

Association between migraine and HLA–DRB1 gene polymorphisms

High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation

CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor

Related objects

Reset password